THE DESIGN, SYNTHESIS AND DEVELOPMENT OF A NEW CLASS OF POTENT ANTINEOPLASTIC ANTHRAQUINONES

被引:109
作者
CHENG, CC [1 ]
ZEECHENG, RKY [1 ]
机构
[1] UNIV KANSAS,MED CTR,MID AMER CANC CTR,DRUG DEV LAB,KANSAS CITY,KS 66103
关键词
D O I
10.1016/S0079-6468(08)70217-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:83 / 118
页数:36
相关论文
共 260 条
  • [1] AAPRO M, 1982, P AN M AM SOC CLIN, V1, P14
  • [2] ADAMSON RH, 1974, CANCER CHEMOTH REP 1, V58, P293
  • [3] ADAMSON RH, 1973, RECENT DEV CANCER CH, P402
  • [4] PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG
    ALBERTS, DS
    GRIFFITH, KS
    GOODMAN, GE
    HERMAN, TS
    MURRAY, E
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) : 11 - 15
  • [5] ANDERSON KC, 1982, CANCER TREAT REP, V66, P1929
  • [6] ARCAMONE F, 1977, LLOYDIA, V40, P45
  • [7] AU WW, 1981, CANCER RES, V41, P376
  • [8] AVRAMIS VI, 1981, P AM ASSOC CANC RES, V22, P210
  • [9] BACHUR NR, 1978, CANCER RES, V38, P1745
  • [10] BACHUR NR, 1975, CANCER CHEMOTHER R 3, V6, P83